174 related articles for article (PubMed ID: 8269614)
21. Cytochromes P450 in cynomolgus monkeys mutagenically activate 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) but not 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx).
Sadrieh N; Snyderwine EG
Carcinogenesis; 1995 Jul; 16(7):1549-55. PubMed ID: 7614688
[TBL] [Abstract][Full Text] [Related]
22. Testosterone production in mature scorbutic mutant rats unable to synthesize ascorbic acid.
Ito Y; Tsuji M; Terada N; Miyano M; Mori H
Int J Androl; 1992 Apr; 15(2):160-9. PubMed ID: 1572729
[TBL] [Abstract][Full Text] [Related]
23. Human enzymes involved in the metabolic activation of the environmental contaminant 3-nitrobenzanthrone: evidence for reductive activation by human NADPH:cytochrome p450 reductase.
Arlt VM; Stiborova M; Hewer A; Schmeiser HH; Phillips DH
Cancer Res; 2003 Jun; 63(11):2752-61. PubMed ID: 12782579
[TBL] [Abstract][Full Text] [Related]
24. Metabolic activation of benzo[a]pyrene in vitro by hepatic cytochrome P450 contrasts with detoxification in vivo: experiments with hepatic cytochrome P450 reductase null mice.
Arlt VM; Stiborová M; Henderson CJ; Thiemann M; Frei E; Aimová D; Singh R; Gamboa da Costa G; Schmitz OJ; Farmer PB; Wolf CR; Phillips DH
Carcinogenesis; 2008 Mar; 29(3):656-65. PubMed ID: 18204078
[TBL] [Abstract][Full Text] [Related]
25. Human hepatic CYP1A1 and CYP1A2 content, determined with specific anti-peptide antibodies, correlates with the mutagenic activation of PhIP.
Murray BP; Edwards RJ; Murray S; Singleton AM; Davies DS; Boobis AR
Carcinogenesis; 1993 Apr; 14(4):585-92. PubMed ID: 8472319
[TBL] [Abstract][Full Text] [Related]
26. Ionic lead, a unique metal ion as an inhibitor for cytochrome P450IA2 (CYP1A2) expression in the rat liver.
Degawa M; Arai H; Kubota M; Hashimoto Y
Biochem Biophys Res Commun; 1994 Apr; 200(2):1086-92. PubMed ID: 8179586
[TBL] [Abstract][Full Text] [Related]
27. Ascorbic acid deficiency decreases the renal level of kidney fatty acid-binding protein by lowering the alpha2u-globulin gene expression in liver in scurvy-prone ODS rats.
Ikeda S; Takasu M; Matsuda T; Kakinuma A; Horio F
J Nutr; 1997 Nov; 127(11):2173-8. PubMed ID: 9349844
[TBL] [Abstract][Full Text] [Related]
28. The effect of certain vitamin deficiencies on hepatic drug metabolism.
Zannoni VG; Sato PH
Fed Proc; 1976 Nov; 35(13):2464-9. PubMed ID: 976490
[TBL] [Abstract][Full Text] [Related]
29. Evidence for the involvement of N-hydroxylation of 3-amino-1-methyl-5H-pyrido[4,3-b]indole by cytochrome P-450 in the covalent binding to DNA.
Mita S; Ishii K; Yamazoe Y; Kamataki T; Kato R; Sugimura T
Cancer Res; 1981 Sep; 41(9 Pt 1):3610-4. PubMed ID: 7020934
[TBL] [Abstract][Full Text] [Related]
30. Aromatase activity and progesterone metabolism in ovaries of scorbutic mutant rats unable to synthesize ascorbic acid.
Tsuji M; Ito Y; Fukuda H; Terada N; Mori H
Int J Vitam Nutr Res; 1989; 59(4):353-9. PubMed ID: 2634041
[TBL] [Abstract][Full Text] [Related]
31. Dietary ascorbic acid depresses plasma and low density lipoprotein lipid peroxidation in genetically scorbutic rats.
Kimura H; Yamada Y; Morita Y; Ikeda H; Matsuo T
J Nutr; 1992 Sep; 122(9):1904-9. PubMed ID: 1512641
[TBL] [Abstract][Full Text] [Related]
32. Metabolic activation of dacarbazine by human cytochromes P450: the role of CYP1A1, CYP1A2, and CYP2E1.
Reid JM; Kuffel MJ; Miller JK; Rios R; Ames MM
Clin Cancer Res; 1999 Aug; 5(8):2192-7. PubMed ID: 10473105
[TBL] [Abstract][Full Text] [Related]
33. Recombinant human P450 forms 1A1, 1A2, and 1B1 catalyze the bioactivation of heterocyclic amine mutagens in Escherichia coli lacZ strains.
Josephy PD; Batty SM; Boverhof DR
Environ Mol Mutagen; 2001; 38(1):12-8. PubMed ID: 11473383
[TBL] [Abstract][Full Text] [Related]
34. Sex-dependent induction of hepatic enzymes for mutagenic activation of a tryptophan pyrolysate component, 3-amino-1,4-dimethyl-5H-pyrido[4,3-b]-indole, by feeding in mice.
Degawa M; Kojima M; Hishinuma T; Hashimoto Y
Cancer Res; 1985 Jan; 45(1):96-102. PubMed ID: 3880668
[TBL] [Abstract][Full Text] [Related]
35. Activation of heterocyclic aromatic amines by rat and human liver microsomes and by purified rat and human cytochrome P450 1A2.
Turesky RJ; Constable A; Richoz J; Varga N; Markovic J; Martin MV; Guengerich FP
Chem Res Toxicol; 1998 Aug; 11(8):925-36. PubMed ID: 9705755
[TBL] [Abstract][Full Text] [Related]
36. The role of highly purified forms of rat liver cytochrome P-450 in the dimethylation of dimethylnitrosamine and its activation to mutagens.
Masson HA; Ioannides C; Gibson GG
Toxicol Lett; 1983 Jun; 17(1-2):131-5. PubMed ID: 6414108
[TBL] [Abstract][Full Text] [Related]
37. The stimulatory role of human cytochrome b5 in the bioactivation activities of human CYP1A2, 2A6 and 2E1: a new cell expression system to study cytochrome P450 mediated biotransformation.
Duarte MP; Palma BB; Gilep AA; Laires A; Oliveira JS; Usanov SA; Rueff J; Kranendonk M
Mutagenesis; 2005 Mar; 20(2):93-100. PubMed ID: 15728263
[TBL] [Abstract][Full Text] [Related]
38. N-hydroxylation of carcinogenic and mutagenic aromatic amines.
Kato R; Kamataki T; Yamazoe Y
Environ Health Perspect; 1983 Mar; 49():21-5. PubMed ID: 6832094
[TBL] [Abstract][Full Text] [Related]
39. Ascorbic acid deficiency changes hepatic gene expression of acute phase proteins in scurvy-prone ODS rats.
Ikeda S; Horio F; Kakinuma A
J Nutr; 1998 May; 128(5):832-8. PubMed ID: 9566989
[TBL] [Abstract][Full Text] [Related]
40. Biotransformation of parathion in human liver: participation of CYP3A4 and its inactivation during microsomal parathion oxidation.
Butler AM; Murray M
J Pharmacol Exp Ther; 1997 Feb; 280(2):966-73. PubMed ID: 9023313
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
